Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Growth Metrics
Income Statement
Others
Ratios

STRATA Skin Sciences (SSKN) Cash from Investing Activities (2016 - 2025)

STRATA Skin Sciences' Cash from Investing Activities history spans 14 years, with the latest figure at -$1.0 million for Q3 2025.

  • For Q3 2025, Cash from Investing Activities fell 1541.94% year-over-year to -$1.0 million; the TTM value through Sep 2025 reached -$1.7 million, up 41.75%, while the annual FY2024 figure was -$1.6 million, 67.4% up from the prior year.
  • Cash from Investing Activities for Q3 2025 was -$1.0 million at STRATA Skin Sciences, down from $61000.0 in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $194000.0 in Q3 2023 and bottomed at -$4.5 million in Q3 2021.
  • The 5-year median for Cash from Investing Activities is -$740000.0 (2021), against an average of -$1.0 million.
  • The largest annual shift saw Cash from Investing Activities surged 136.81% in 2023 before it tumbled 1541.94% in 2025.
  • A 5-year view of Cash from Investing Activities shows it stood at -$1.1 million in 2021, then tumbled by 50.35% to -$1.7 million in 2022, then fell by 1.12% to -$1.7 million in 2023, then skyrocketed by 70.66% to -$504000.0 in 2024, then crashed by 101.98% to -$1.0 million in 2025.
  • Per Business Quant, the three most recent readings for SSKN's Cash from Investing Activities are -$1.0 million (Q3 2025), $61000.0 (Q2 2025), and -$199000.0 (Q1 2025).